Navigation Links
ACTwatch, to Improve Malaria Treatment, to Be Launched on World Malaria Day

NAIROBI, Kenya, April 24 /PRNewswire-USNewswire/ -- A multi-country project called ACTwatch, which will monitor the availability and affordability of effective malaria treatment, will be launched in Nairobi Friday -- World Malaria Day. Over the next five years, ACTwatch, which is funded by a grant from the Bill & Melinda Gates Foundation, will provide ongoing evidence related to access to antimalarials, specifically artemisinin-based combination therapies (ACTs), the most effective malaria treatment on the market. This evidence will inform policy discussions ongoing at both the global and country level to increase access to effective antimalarials for those who need them most.

ACTwatch is being implemented by a consortium of partners led by the nongovernmental organization PSI. Other partners include the London School of Hygiene and Tropical Medicine, United States Pharmacopeia and the market research firm, Nielsen. The project will be carried out in six African countries (Benin, Democratic Republic of Congo, Madagascar, Nigeria, Uganda and Zambia) and two countries in Southeast Asia (Cambodia and one other, yet to be decided upon).

Studies conducted under the auspices of the project will examine the price, availability and quality of different types of antimalarials in shops and health facilities. Studies will also investigate malaria treatment seeking behavior in the community and the functioning of the supply chain for antimalarials as well as look at the effect of government policies on the structure of the antimalarial market in each country. The principal outputs of ACTwatch will be evidence on changes in the availability, affordability and use of ACTs, in all sectors, as well as policy recommendations targeting national and international decision-makers to increase use of ACTs in vulnerable communities.

Over the past two to three years, ACTs have become the malaria treatment of choice and have replaced drugs, such as chloroquine, which have become ineffective due to the emergence of resistant malaria parasites. While ACTs are extremely effective in treating malaria, they are sold for up to 10 times the price of chloroquine. As a result, major donor initiatives, such as the Global Fund to Fight AIDS, Tuberculosis and Malaria, have provided funds to individual countries to procure ACTs for supply through public health facilities to treat patients sick with malaria.

While public facilities in most malaria endemic countries provide ACTs at low cost or for free, almost half of all malaria patients access treatment through shops, where many kinds of antimalarials, of varying quality, can be found. Few shops stock ACTs because they are so expensive and most patients continue to buy ineffective malaria treatments because that is all that they can afford. To address this problem, both global and national financing initiatives to subsidize the price of ACTs are underway. ACTwatch will provide ongoing feedback to these programs, and measure the extent to which these initiatives have been successful.

For more information on ACTwatch, visit

The mission of PSI is to measurably improve the health of poor and vulnerable people in the developing world, principally through social marketing of family planning and health products and services, and behavior change communications. Social marketing engages private sector resources and uses private sector techniques to encourage healthy behavior and make markets work for the poor.

SOURCE Population Services International
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Vision restoration therapy shown to improve brain activity in brain injured patients
2. Broad-based group of physicians calls for improvement in stroke treatment
3. Frequent Prostate Screens Fail to Improve Aggressive Cancer Diagnoses
4. Pill box organizers increase HIV patients adherence and improve viral suppression
5. Treating depression may improve recovery of heart rate variability following coronary syndromes
6. Study Demonstrates Marteks Algal DHA Oil Improves Blood Triglyceride Lipid Levels
7. AWWA, National Association of Water and Sanitation of Mexico, Agree to Share Expertise and Resources for Improved Water Supply
8. Exercise and yoga improves quality of life in women with early-stage breast cancer
9. QI projects may -- or may not -- improve patient safety and outcomes
10. National Association for Sport and Physical Education Partners with S&S Worldwide to Help Improve Childrens Fitness
11. MedQuist Re-launches New, Improved Web Site
Post Your Comments:
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
(Date:6/24/2016)... ... ... Comfort Keepers® of San Diego, CA is excited to announce they are ... drive cancer patients to and from their cancer treatments. Comfort Keepers provides quality ... and ongoing independence. Getting to and from medical treatments is one of the ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations at ... Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Consumers have taken ... regulators/payers have placed more emphasis on patient outcomes. ... support programs in the pharmaceutical industry have evolved ... Consequently, pharmaceutical companies are focusing on becoming more ... providing products and services that improve health. ...
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... 24, 2016 ... the addition of the " Global Markets for ... This report focuses on ... updated review, including its applications in various applications. The ... which includes three main industries: pharmaceutical and biotechnology, food ...
Breaking Medicine Technology: